Previous close | 13.66 |
Open | 17.08 |
Bid | 13.57 x 100 |
Ask | 15.90 x 100 |
Day's range | 14.87 - 17.99 |
52-week range | 6.46 - 35.67 |
Volume | |
Avg. volume | 3,730,036 |
Market cap | 2.454B |
Beta (5Y monthly) | 2.32 |
PE ratio (TTM) | 176.44 |
EPS (TTM) | 0.09 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 30.43 |
Despite a net loss, TG Therapeutics Inc reports significant revenue increases and strategic advancements in Q1 2024, setting a positive trajectory for the year.
Q1 2024 TG Therapeutics Inc Earnings Call
Comprehensive Analysis of TG Therapeutics' First Quarter Financial Performance